Successful treatment of platelet transfusion refractoriness. The use of platelet transfusions matched for both human leucocyte antigens (HLA) and human platelet alloantigens (HPA) in alloimmunized leukaemia patients

被引:0
|
作者
Kekomaki, S
Volin, L
Koistinen, P
Koivunen, E
Timonen, T
Kekomaki, R
机构
[1] FINNISH RED CROSS & BLOOD TRANSFUS SERV, SF-00310 HELSINKI, FINLAND
[2] UNIV HELSINKI HOSP, HELSINKI, FINLAND
[3] OULU UNIV HOSP, OULU, FINLAND
[4] TAMPERE UNIV HOSP, TAMPERE, FINLAND
关键词
D O I
暂无
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
引用
收藏
页码:PS315 / PS315
页数:1
相关论文
共 35 条
  • [21] USE OF LEUCOCYTE-POOR BLOOD PRODUCTS AND HLA-MATCHED DONORS TO PREVENT ALLOIMMUNIZATION BY PLATELET TRANSFUSION
    MURPHY, MF
    METCALFE, P
    THOMAS, H
    EVE, J
    ORD, J
    LISTER, TA
    WATERS, AH
    BRITISH JOURNAL OF HAEMATOLOGY, 1985, 61 (03) : 555 - 555
  • [22] Clinical evaluation of patients with refractoriness to platelet transfusions due to alloimmunisation to HLA antigens after haematopoitic stem cell transplantation
    Sanchez-Ramirez, J. M.
    Munoz-Novas, C.
    Perez-Corral, A.
    Anguita, J.
    Gomez-Pineda, A.
    Kwon, M.
    Rodriguez-Macias, G.
    Serrano, D.
    Carrion, R.
    Buno, I.
    Balsalobre, P.
    Ortega, B.
    Moreno, R.
    Diez-Martin, J. L.
    BONE MARROW TRANSPLANTATION, 2008, 41 : S94 - S94
  • [23] Use of recombinant factor VIIa in treatment of bleeding episodes for patients with refractoriness to platelet transfusion therapy
    Sandilya, Vijay
    Gupta, Namita
    BLOOD, 2012, 120 (21)
  • [24] Use of Human Leukocyte Antigen (HLA)-Incompatible Platelet Units in HLA Platelet-Refractory Patients With Limited Number of or Low-Level HLA Donor-Specific Antibodies Results in Permissive Transfusions
    Sullivan, Jensyn Cone
    Pena, Jeremy Ryan
    ARCHIVES OF PATHOLOGY & LABORATORY MEDICINE, 2022, 146 (10) : 1243 - 1251
  • [25] Antibodies against human platelet alloantigens and human leucocyte antigen class 1 in Saudi Arabian multiparous women and multi-transfused patients
    Al-Ouda, Sarah K.
    Al-Banyan, Abdulmajeed A.
    Al-Gahtani, Farjah H.
    Abdel-Gader, Abdel-Galil M.
    Al-Dakhil, Lateefa O.
    SAUDI MEDICAL JOURNAL, 2015, 36 (06) : 664 - 669
  • [26] Allelic Frequencies of HPA-1 to 5 Human Platelet Antigens in Patients Infected With Hepatitis C Virus
    Verdichio-Moraes, Camila Fernanda
    Toralles-Pereira, Cecilia
    Tommasini Grotto, Rejane Maria
    Silva, Giovanni Faria
    de Moura Campos Pardini, Maria Ines
    JOURNAL OF MEDICAL VIROLOGY, 2009, 81 (04) : 757 - 759
  • [27] Should HLA and HPA-matched platelet transfusions for patients with Glanzmann Thrombasthenia or Bernard-Soulier syndrome be standardized care? A Dutch survey and recommendations
    Huisman, Elise J.
    Holle, Nory
    Schipperus, Martin
    Cnossen, Marjon H.
    de Haas, Masja
    Porcelijn, Leendert
    Zwaginga, Jaap-Jan
    TRANSFUSION, 2024, 64 (05) : 824 - 838
  • [28] The use of splenectomy to manage platelet transfusion refractoriness due to anti-human leukocyte antibodies in allogeneic stem cell transplantation
    Mauro, Margherita
    Camoglio, Francesco
    Piccoli, Pierluigi
    De Bortoli, Massimiliano
    Balter, Rita
    Pegoraro, Anna
    Cesaro, Simone
    PEDIATRIC REPORTS, 2016, 8 (01) : 1 - 3
  • [29] A case study of a patient with platelet transfusion refractoriness (PTR) combined with human leucocyte antigen (HLA) antibody positivity during hepatic arterial infusion chemotherapy in conjunction with the 'atezolizumab plus bevacizumab' regimen
    Xie, Yawen
    Huang, Yanxia
    Liu, Shuyue
    NURSING IN CRITICAL CARE, 2025, 30 (02)
  • [30] PRODUCTION OF ALLOGENIC ANTIBODIES TO LEUKOCYTE AND PLATELET ANTIGENS (ANTI-HLA AND ANTI-HPA) IN PATIENTS WITH BLOOD SYSTEM DISEASES, RECEIVING TRANSFUSIONS OF BLOOD COMPONENTS
    Glazanova, T., V
    Gritsaev, S., V
    Shilova, E. R.
    Pavlova, I. E.
    Chubukina, Zh., V
    Rozanova, O. E.
    Abdulkadyrova, K. M.
    Chechetkin, A., V
    Bubnova, L. N.
    GEMATOLOGIYA I TRANSFUZIOLOGIYA, 2015, 60 (04): : 26 - 29